Varenicline stubs out the competition in smoking cessation

October 2007
PharmacoEconomics & Outcomes News;10/20/2007, Issue 539, p8
The article highlights the findings of a study titled "Cost-effectiveness of varenicline for smoking cessation in the Netherlands." According to the study, varenicline is cost-effective as compared to bupropion and nicotine replacement therapy. The Benefits of Smoking Cessation on Outcomes model was employed in the study to assess the long-term economic and health benefits of smoking cessation among a cohort of smokers making a one-time quit attempt.


Related Articles

  • Smoking cessation plan shows short-term cost benefits in HK.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p6 

    The article discusses research study on the cost effectiveness of a low-intensity smoking cessation programme, referencing a study by S. S. Chan and colleagues presented at the 17th World Congress of Cardiology.

  • A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand. Thavorn, K.; Chaiyakunapruk, N. // Tobacco Control;Jun2008, Vol. 17 Issue 3, p177 

    Objective: To estimate the incremental cost-effectiveness ratio of a structured community pharmacist-based smoking cessation programme compared with usual care. Design: A cost-effectiveness study using a healthcare system perspective Population: Two simulated cohorts of smokers: male and female...

  • Potential Costs and Benefits of Statewide Smoking Cessation in Pennsylvania. Rumberger, Jill S.; Hollenbeak, Christopher S. // Journal of Smoking Cessation;Oct2010, Vol. 5 Issue 2, p136 

    Objectives: To determine whether the cost of a statewide smoking cessation program in Pennsylvania could be justified by the benefits. Methods: A cost-benefit analysis of statewide access to smoking cessation programs. We compared three treatment alternatives, with and without counselling:...

  • Smoking Cessation Education and Training in U.K. Medical Schools: A National Survey. Raupach, Tobias; Al-Harbi, Ghada; McNeill, Ann; Bobak, Alex; McEwen, Andy // Nicotine & Tobacco Research;Mar2015, Vol. 17 Issue 3, p372 

    Introduction: Smoking cessation is one of the most cost-effective of all health interventions. Physicians are in a strong position to encourage smokers to make a quit attempt and to help them achieve long-term abstinence. Formal teaching on tobacco-related disease, the evidence base of smoking...

  • Identifying Barriers to Entering Smoking Cessation Treatment Among Socioeconomically Disadvantaged Smokers. Copeland, Amy L.; Businelle, Michael S.; Stewart, Diana W.; Patterson, Scott M.; Rash, Carla J.; Carney, Colleen E. // Journal of Smoking Cessation;Oct2010, Vol. 5 Issue 2, p164 

    Background: Efficacious smoking cessation interventions exist, yet few smokers utilise available resources such as psychosocial treatment programs and pharmacotherapy. The goals of the present study were to (1) identify perceived barriers to entering smoking cessation treatment programs among...

  • Commentary: Putting the research into practice. Rigotti, Nancy A // BMJ: British Medical Journal (International Edition);12/13/2003, Vol. 327 Issue 7428, p1395 

    Comments on putting research on helping smokers quit into practice. The selection of treatments including pharmacotherapy and counselling; Use of nicotine-replacement drugs.

  • Effects of frequency and duration in telephone counselling for smoking cessation. Rabius, V.; Pike, K. J.; Hunter, J.; Wiatrek, D.; McAlister, A. L. // Tobacco Control;Dec2007 Supplement 1, Vol. 16, pi71 

    Objective: This study evaluates alternative protocols in telephone counselling for smoking cessation. Design: The American Cancer Society enrolled 6322 clients in a randomised trial comparing three counselling formats of varying duration and frequency of contact, with or without booster...

  • Reduced NRT supplies through a quitline: Smoking cessation differences. Burns, Emily K.; Suhong Tong; Levinson, Arnold H. // Nicotine & Tobacco Research;Aug2010, Vol. 12 Issue 8, p845 

    Introduction:: Quitlines (QLs) provide effective smoking cessation treatment. The most cost-effective protocol for nicotine replacement therapy (NRT) has not been established. The current study compares self-reported 7-day abstinence rates among light to moderate smokers (≤20 cigarettes...

  • Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia. Bertram, Melanie Y.; Lim, Stephen S.; Wallace, Angela L.; Vos, Theo // Tobacco Control;Aug2007, Vol. 16 Issue 4, p255 

    Background: Tobacco smoking is the leading preventable cause of morbidity and mortality in Australia and other developed countries. Of the pharmacological aids that are available for smoking cessation, bupropion (Zyban SR) is eligible for public reimbursement on the Australian Pharmaceutical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics